Medicare Enrolled
Dr. Ramin Mirhashemi, M.D.
Gynecologic Oncology Physician · Torrance, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mirhashemi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mirhashemi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mirhashemi
Dr. Ramin Mirhashemi is a gynecologic oncology physician in Torrance, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Mirhashemi performed 41,452 Medicare services across 886 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mirhashemi received a total of $51,708 from 65 pharmaceutical and/or device companies across 390 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gynecologic oncology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mirhashemi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 2% volume in CA
$51,708 industry payments
Medicare Practice Summary
Medicare Utilization ↗41,452
Medicare services
Top 2% in CA for gynecologic oncology physician
886
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,182 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Paclitaxel chemotherapy injection | 23,367 | $0 | $9 |
| Bevacizumab-bvzr biosimilar injection, 10 mg An injection of bevacizumab-bvzr, a biosimilar medication, administered in a 10 mg dose. |
6,243 | $25 | $190 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
5,330 | $0 | $7 |
| Anti-nausea injection (Aloxi/palonosetron) | 2,650 | $1 | $53 |
| Injection, granisetron hydrochloride, 100 mcg | 980 | $0 | $25 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
596 | $2 | $170 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
396 | $14 | $60 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
358 | $119 | $520 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
356 | $26 | $110 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
292 | $98 | $348 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
216 | $1 | $17 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
177 | $59 | $250 |
| Pelvic and clinical breast exam for cancer screening A physical examination of the pelvis and breasts to screen for cervical or vaginal cancer. This procedure involves a clinical assessment performed by a healthcare provider. |
86 | $43 | $136 |
| New patient office visit, complex (60-74 min) | 78 | $174 | $570 |
| Pap smear screening test A screening test to collect and prepare a cervical or vaginal sample for laboratory analysis. |
60 | $49 | $150 |
| Release of scar tissue at ureter A procedure to remove scar tissue from the ureter to restore normal urine flow. |
30 | $957 | $7,094 |
| Complete pelvic ultrasound An imaging test using sound waves to create pictures of the organs and structures within the pelvis. |
29 | $93 | $390 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
29 | $66 | $190 |
| Transvaginal pelvic ultrasound An ultrasound exam using a probe inserted into the vagina to image the uterus, ovaries, fallopian tubes, cervix, and surrounding pelvic structures. |
28 | $107 | $440 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
26 | $25 | $110 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
21 | $140 | $540 |
| Laparoscopic hysterectomy with pelvic lymph node removal Surgical removal of the uterus and cervix through small incisions using a camera. Pelvic lymph nodes are also removed, and a biopsy is taken from the aortic lymph nodes. |
19 | $1,589 | $6,651 |
| Endometrial biopsy or polyp removal A procedure to collect a tissue sample from the uterine lining or remove a polyp using a thin, lighted tube inserted through the cervix. |
18 | $1,251 | $5,080 |
| Central venous port insertion A surgical procedure to place a small reservoir under the skin for long-term access to the bloodstream. The device is connected to a vein to allow for repeated medication administration or blood draws. |
15 | $276 | $3,922 |
| Ultrasound guidance for blood vessel access Use of ultrasound imaging to help locate and access a blood vessel. This guidance assists healthcare providers in performing procedures such as inserting IV lines or drawing blood. |
15 | $12 | $50 |
| Endometrial biopsy A procedure to remove a small sample of tissue from the lining of the uterus for examination. |
13 | $45 | $310 |
| Ureteral stent insertion via cystoscopy A tube is placed into the ureter using an endoscope inserted through the bladder. |
12 | $24 | $1,000 |
| Laparoscopic hysterectomy with salpingo-oophorectomy, 250g or less Surgical removal of the uterus, fallopian tubes, and/or ovaries through small abdominal incisions using a camera-guided instrument. The procedure is specified for cases where the removed tissue weighs 250 grams or less. |
12 | $610 | $2,997 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.2% high complexity
96.3% medium
1.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$51,708
Total received (2018-2024)
Avg $7,387/year across 7 years
Top 12% in CA for gynecologic oncology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
65
Companies
390
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$25,353 (49.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,464 (29.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$10,891 (21.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,456
2023
$3,136
2022
$2,164
2021
$24,062
2020
$6,478
2019
$6,678
2018
$7,735
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$285
GlaxoSmithKline, LLC.
$212
AstraZeneca Pharmaceuticals LP
$201
INTUITIVE SURGICAL, INC.
$130
Myriad Genetic Laboratories, Inc.
$123
ABBVIE INC.
$100
PFIZER INC.
$95
Merck Sharp & Dohme LLC
$53
Boston Scientific Corporation
$49
Amneal Pharmaceuticals LLC
$46
Ethicon US, LLC
$37
Baxter Healthcare
$29
Urgo Medical North America, LLC
$27
Teleflex LLC
$21
CONMED Corporation
$19
Smith+Nephew, Inc.
$16
Axonics, Inc.
$14
Top 3 companies account for 48.0% of 2024 payments
All-time payments by company (2018-2024) ›
Biom'Up France SAS
$25,639
Intuitive Surgical, Inc.
$4,283
TESARO, Inc.
$3,059
Stryker Corporation
$2,566
Covidien LP
$2,369
AbbVie Inc.
$2,154
Medtronic, Inc.
$1,828
Allergan Inc.
$1,143
GlaxoSmithKline, LLC.
$953
AstraZeneca Pharmaceuticals LP
$613
Coloplast Corp
$591
BAXTER HEALTHCARE
$590
Myriad Genetic Laboratories, Inc.
$486
New Wave Endo-Surgical Corp.
$464
Baxter Healthcare
$420
Clovis Oncology, Inc.
$344
COLOPLAST CORP
$338
Merck Sharp & Dohme Corporation
$237
Merck Sharp & Dohme LLC
$237
Ethicon US, LLC
$220
Dilon Technologies, Inc.
$209
Boston Scientific Corporation
$207
Allergan, Inc.
$181
Biom'Up SA
$166
Helsinn Therapeutics (U.S.), Inc.
$155
Genentech USA, Inc.
$140
ABBVIE INC.
$131
INTUITIVE SURGICAL, INC.
$130
PFIZER INC.
$127
Memic Innovative Surgery Inc.
$126
ACELL, INC.
$126
Pacira Pharmaceuticals Incorporated
$125
Gilead Sciences, Inc.
$125
Eisai Inc.
$100
AbbVie, Inc.
$84
Gynesonics, Inc.
$78
Foundation Medicine, Inc.
$76
ImmunoGen, Inc.
$70
Heron Therapeutics, Inc.
$64
Minerva Surgical, Inc
$64
Smith+Nephew, Inc.
$59
Myovant Sciences Inc.
$51
Seagen Inc.
$48
Amneal Pharmaceuticals LLC
$46
DySIS Medical, Inc.
$44
Davol Inc.
$42
EISAI INC.
$36
Olympus America Inc.
$28
DAVOL INC.
$28
Integra LifeSciences Corporation
$27
Urgo Medical North America, LLC
$27
Agiliti Surgical, Inc.
$26
Tactile Systems Technology Inc
$26
Sumitomo Pharma America, Inc.
$25
Teleflex LLC
$21
Hologic, LLC
$20
Avanos Medical
$19
CooperSurgical, Inc.
$19
CONMED Corporation
$19
Trevena, Inc.
$15
Musculoskeletal Transplant Foundation Inc.
$15
Axonics, Inc.
$14
Aspira Women's Health Inc
$13
KARL STORZ Endoscopy-America
$12
Astellas Pharma US Inc
$11
Top 3 companies account for 63.8% of all-time payments
Associated products mentioned in payments ›
30 · 35 cm · 5mm x 29cm · ADVANTAGE FIT · AIRSEAL · AKYNZEO · ALLODERM · ALTIS · ARISTA AH · AVASTIN · Altis · Anovo Surgical System · Avastin · Axonics · BIOFIX · BOTOX · BOTOX COSMETIC · CAPIO · DYSIS Ultra · Da Vinci Surgical System · ELAHERE · ENSEAL Product Family · ENTEREG · ETHICON · ETHICON ENDO-SURGERY Curved Intraluminal Stapler · EXPAREL · Echelon; Endopath · Elahere · Endo GIA · Enseal · Enseal X1 · FEMALE INCONTINENCE · FLEXITOUCH · FLOSEAL · FOUNDATIONONE · Front-actuated Grip Type S · HEMOBLAST BELLOWS · HOPKINS II · HemoBlast Bellows · Hemoblast · JEMPERLI · KEYTRUDA · LIGASURE · LINZESS · LO LOESTRIN FE · LYNPARZA · Lenvima · LigaSure · Lupron · MYFEMBREE · MYRBETRIQ · MYRISK · Mara Console · OASIS MICRO · ON-Q PUMP AND ACCESSORIES · OVA1 · Olinvyk · Orilissa · PELVIC FLOOR REPAIR · PERCLOT · PI · PRECISETUMOR · PREMARIN · Phasix · Rubraca · SIGNIA · SOLESTA · SOLYX · SONATA SONOGRAPHY-GUIDED TRANSCERVICAL FIBROID ABLATION SYSTEM · SONICISION · STRATTICE · STRATTICE RECONSTRUCTIVE TISSUE MATRIX BPS · STRAVIX · STRAVIX PL · SUPRIS · SUTENT · Saffron · Signia · Solyx SIS System · Sonicision · Surgicel Powder · Sustol · TELESCOPE · THUNDERBEAT 5 mm · TISSEEL · TIVDAK · Trich · Upsylon · VARUBI · VASHE WOUND SOLUTION 250 ML (8.5 FL OZ) FLIP TOP CAP · VISTASEAL · VITAGEL · Valleylab · Valleylab FT10 · XENFORM · ZEJULA · Zynrelef · iDrive
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (49%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in gynecologic oncology physician and does not inherently indicate bias, but patients may wish to be aware.
Geographic Context
Gynecologic oncology physicians within 10 mi
24
Per 100K population
0.2
County median income
$87,760
Nearest hospital
DEL AMO HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Mirhashemi is a mixed practice specialist, with above-average Medicare volume (top 2% in CA), with speaking/promotional industry engagement in the top 12% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Mirhashemi experienced with paclitaxel chemotherapy injection?
Based on Medicare claims data, Dr. Mirhashemi performed 23,367 paclitaxel chemotherapy injection services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mirhashemi receive payments from pharmaceutical companies?
Yes. Dr. Mirhashemi received a total of $51,708 from 65 companies across 390 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mirhashemi's costs compare to other gynecologic oncology physicians in Torrance?
Dr. Mirhashemi's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mirhashemi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Gynecologic Oncology Physicians in Torrance
Browse gynecologic oncology physicians in Torrance ranked by procedure volume and transparency data.
Highest volume
Top Gynecologic Oncology Physicians in CA
Gynecologic oncology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Gynecologic Oncology Physicians in CA
Which CA gynecologic oncology physicians receive the most from drug and device companies.
By company
Biom'Up France SAS Payments to Doctors
See all physicians who received payments from Biom'Up France SAS.
By company
Intuitive Surgical, Inc. Payments to Doctors
See all physicians who received payments from Intuitive Surgical, Inc.
By company
TESARO, Inc. Payments to Doctors
See all physicians who received payments from TESARO, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology